as noted above , possible revenues are projected for the first time, costs are unknown, a cap raising will be required, CE mark uncertainty , future EPS calulations need to account for coming dilution. Great product but long timeframes to meaningful profits even accounting for the market to anticipate and price in future earnings
I'm still on the sidelines for the moment.
